Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Pfizer files third-gen ALK inhibitor for lung cancer

The US FDA is set to make a decision on lorlatinib later this year

- PMLiVE

Bedrock Communications strengthens operations

Agency appoints six new team members

Ashfield appoints former Havas Health CEO

Doug Burcin becomes president at the agency

- PMLiVE

The bulk of pharma digital spend fails to alter industry’s greenhorn status

Indegene’s Digital Maturity study reveals huge gaps in KPIs

The good, the bad and the ugly

Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends

- PMLiVE

Boehringer abandons PDE-targeted Alzheimer’s drug

But will keep testing the candidate in schizophrenia

Roche Basel Switzerland

NICE backs Roche’s Gazyvaro after initial rejection

An undisclosed discount swayed the cost-effectiveness body

Novartis telemedicine service to be ramped up in Ghana

Country's health service selects it as part of the national eHealth strategy

- PMLiVE

NICE backs EUSA’s RCC treatment Fotivda

The UK’s cost-effectiveness watchdog recommends its first-line use

- PMLiVE

Avril Lee joins Burson-Marsteller in global role

Based in the UK, she joins the firm as its deputy global healthcare practice chair

- PMLiVE

A catalyst for change

China’s plan to boost innovation and improve drug accessibility

- PMLiVE

Rubius Therapeutics adds to its board of directors

Francis Cuss and Catherine Sohn join the US biotech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links